Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelopathy”

8,202 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,202 results

Testing effectiveness (Phase 2)Study completedNCT04269889
What this trial is testing

Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag

Who this might be right for
Anemia, Diamond-Blackfan
National Heart, Lung, and Blood Institute (NHLBI) 15
Post-approval studies (Phase 4)Study completedNCT03598582
What this trial is testing

Biological Predictive Factors of Response to ESA in Low Risk MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine 70
Testing effectiveness (Phase 2)Ended earlyNCT03655080
What this trial is testing

Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression

Who this might be right for
Cord Compression
Washington University School of Medicine 2
Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Testing effectiveness (Phase 2)Study completedNCT00551291
What this trial is testing

NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 10
Large-scale testing (Phase 3)Study completedNCT05156320
What this trial is testing

Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 2+7 more
Scholar Rock, Inc. 188
Testing effectiveness (Phase 2)UnknownNCT00003827
What this trial is testing

Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
ALZA 25
Not applicableLooking for participantsNCT06164561
What this trial is testing

18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

Who this might be right for
Myelofibrosis
First Affiliated Hospital of Zhejiang University 57
Not applicableWithdrawnNCT05207826
What this trial is testing

Detrusor Activity Recovery in Acute Traumatic Spinal Cord Injuries

Who this might be right for
Spinal Cord InjuriesNeurogenic BladderSpinal Shock
Pusan National University Yangsan Hospital
Testing effectiveness (Phase 2)Active Not RecruitingNCT04258943
What this trial is testing

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Who this might be right for
Philadelphia Chromosome Positive CMLAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous Leukemia+1 more
Children's Oncology Group 60
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Not applicableStudy completedNCT02376374
What this trial is testing

OPV Transmissibility in Communities After Cessation of Routine OPV Immunization

Who this might be right for
Polio
Stanford University 1,828
Testing effectiveness (Phase 2)Study completedNCT00036413
What this trial is testing

A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Novartis Pharmaceuticals 44
Not applicableUnknownNCT06364813
What this trial is testing

Co-developing a Novel Intervention to Promote Wellbeing of Family Caregivers of Individuals With Spinal Cord Injury

Who this might be right for
Spinal Cord InjuriesCaregiver Burden
University of British Columbia 40
Not applicableStudy completedNCT03369080
What this trial is testing

Prospective Survey of Body Mass Index in People With Spinal Cord Injury.

Who this might be right for
Spinal Cord Injuries
Rigshospitalet, Denmark 98
Not applicableActive Not RecruitingNCT05548062
What this trial is testing

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals 242
Not applicableLooking for participantsNCT06042946
What this trial is testing

Microsurgical Resection of Intramedullary Spinal Cord Metastases

Who this might be right for
Spinal Cord MetastasisSpinal Cord Tumor Malignant IntramedullaryFunctional Outcome+2 more
Cantonal Hospital of St. Gallen 60
Not applicableActive Not RecruitingNCT05619146
What this trial is testing

Arm and Leg Cycling for Accelerated Recovery From SCI

Who this might be right for
Spinal Cord Injuries
Shirley Ryan AbilityLab 5
Not applicableStudy completedNCT05334342
What this trial is testing

Low-GI Diet Vs High-GI Diet in Individuals with SCI

Who this might be right for
Spinal Cord InjuriesPostprandial HypotensionGlucose Metabolism Disorders
Ohio State University 11
Testing effectiveness (Phase 2)Ended earlyNCT00720850
What this trial is testing

Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Who this might be right for
Myelodysplastic SyndromesAcute Myelogenous Leukemia
Technische Universität Dresden 10
Load More Results